Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LQDA | LIQUIDIA CORP | $56.93 | $18.62 | 205.78% | 237.21x | 17.17x | 17.39x | 46.63x | 1.12x | $41.15M | 0.82% | $108.58M | 1.23 | $5.02B | 93.73 | ||
| SLNO | SOLENO THERAPEUTICS INC | $53.01 | $60.69 | -12.65% | 28.65x | 13.16x | 9.69x | 5.57x | 0.36x | $105.42M | 3.82% | $495.80M | 9.52 | $2.68B | 24.95 | ||
| CORT | CORCEPT THERAPEUTICS INC | $56.37 | $19.19 | 193.75% | 122.54x | 107.66x | 7.65x | 9.49x | 1.15x | $119.79M | 2.03% | $637.99M | 6.11 | $5.95B | -866.93 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $286.98 | $95.94 | 199.12% | 65.82x | 38.91x | 8.90x | 35.63x | 1.35x | $641.34M | 1.68% | $1.08B | 8.09 | $39.57B | 42.81 | ||
| KRYS | KRYSTAL BIOTECH INC | $306.29 | $97.42 | 214.42% | 39.52x | 37.88x | 21.50x | 7.07x | 1.88x | $237.38M | 2.65% | $1.28B | 43.59 | $8.54B | 39.90 | ||
| ADMA | ADMA BIOLOGICS INC | $8.27 | $10.68 | -22.55% | 11.99x | 8.33x | 3.83x | 4.91x | 0.41x | $107.90M | 5.53% | $390.33M | 1.65 | $1.98B | 8.92 | ||
| OMER | OMEROS CORP | $12.25 | $15.81 | -22.52% | 9.42x | -32.17x | 88.77x | -14.00x | 0.47x | -$94.78M | -10.76% | -$63.33M | -0.88 | $1.20B | 13.22 | ||
| ASND | ASCENDIS PHARMA A | $240.50 | $85.31 | 181.91% | 25.49x | 19.36x | 14.67x | 26.02x | 2.37x | $52.94M | 0.35% | $574.09M | 9.24 | $15.32B | 164.27 | ||
| XERS | XERIS BIOPHARMA HOLDINGS INC | $6.24 | $2.88 | 116.96% | 89.14x | 52.22x | 3.38x | 82.80x | 0.85x | $47.52M | 4.47% | $13.01M | 0.08 | $1.22B | 22.91 | ||
| VCEL | VERICEL CORP | $33.03 | $9.30 | 255.00% | 76.81x | 68.51x | 5.74x | 4.74x | 1.62x | $47.49M | 2.83% | $356.23M | 7.02 | $1.67B | 41.37 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $11.01 | $16.56 | -33.52% | 5.37x | 23.43x | 5.26x | 3.16x | 0.68x | $56.42M | 8.77% | $205.80M | 3.52 | $556.41M | 3.85 | ||
| HALO | HALOZYME THERAPEUTICS INC | $67.12 | $71.81 | -6.53% | 22.68x | 8.10x | 5.26x | 36.25x | 0.41x | $667.65M | 8.42% | $219.64M | 1.86 | $9.79B | 15.70 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $51.81 | $41.58 | 24.59% | 37.01x | 13.04x | 3.08x | 1.61x | 0.52x | $767.06M | 7.69% | $6.21B | 32.27 | $8.37B | 17.35 | ||
| RPRX | ROYALTY PHARMA PLC | $52.85 | $40.62 | 30.12% | 27.67x | 9.91x | 9.46x | 3.06x | 0.60x | $2.34B | 10.14% | $9.94B | 22.75 | $38.80B | 33.35 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $213.21 | $97.45 | 118.79% | 26.99x | 23.66x | 15.44x | 4.28x | 1.33x | $122.22M | 2.88% | $997.32M | 50.16 | $4.61B | 20.44 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $228.77 | $49.64 | 360.83% | 486.74x | 8.86x | 3.19x | 3.17x | 1.66x | $1.30B | 9.16% | $4.53B | 73.22 | $17.91B | 26.53 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $56.51 | $16.19 | 249.09% | 57.66x | 51.23x | 5.73x | 7.18x | 1.77x | $164.23M | 3.80% | $605.69M | 7.92 | $4.17B | 37.38 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $30.09 | $36.51 | -17.59% | 11.89x | 8.20x | 1.94x | 1.91x | 0.45x | $341.79M | 19.64% | $910.35M | 15.75 | $1.31B | 5.53 | ||
| TECH | BIO-TECHNE CORP | $43.30 | $15.67 | 176.33% | 60.99x | 22.02x | 5.59x | 3.25x | 1.25x | $269.60M | 3.98% | $2.09B | 13.34 | $6.86B | 26.80 | ||
| SPRO | SPERO THERAPEUTICS INC | $2.79 | $5.84 | -52.23% | 10.33x | 4.08x | 2.61x | 3.05x | 0.22x | $7.24M | 4.52% | $52.93M | 0.92 | $107.89M | 6.96 | ||
| TGTX | TG THERAPEUTICS INC | $39.50 | $18.96 | 108.31% | 12.27x | 26.32x | 8.15x | 10.37x | 8.02x | -$14.19M | -0.25% | $583.13M | 4.04 | $6.35B | 42.37 | ||
| EXEL | EXELIXIS INC | $50.13 | $31.41 | 59.60% | 16.07x | 15.22x | 5.45x | 6.51x | 1.17x | $917.69M | 7.09% | $1.94B | 7.49 | $12.54B | 11.88 | ||
| UTHR | UNITED THERAPEUTICS CORP | $568.58 | $251.89 | 125.72% | 19.42x | 19.56x | 7.80x | 4.09x | 2.05x | $1.02B | 4.11% | $5.90B | 135.66 | $22.85B | 13.34 | ||
| NAGE | NIAGEN BIOSCIENCE INC | $3.65 | $2.50 | 45.73% | 15.21x | 15.43x | 2.24x | 3.53x | 1.03x | $4.11M | 1.40% | $82.33M | 1.03 | $226.73M | 10.67 | ||
| CPRX | CATALYST PHARMACEUTICALS INC | $31.18 | $15.17 | 105.51% | 17.23x | 16.21x | 6.39x | 3.77x | 1.95x | $208.13M | 5.46% | $1.01B | 8.28 | $3.06B | 9.14 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $436.95 | $172.85 | 152.79% | 25.69x | 22.33x | 9.09x | 5.73x | 1.83x | $3.71B | 3.34% | $19.36B | 76.20 | $107.39B | 19.91 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $698.25 | $451.01 | 54.82% | 16.41x | 14.77x | 4.87x | 2.33x | 1.07x | $4.11B | 5.66% | $31.42B | 302.15 | $72.95B | 12.70 | ||
| VCYT | VERACYTE INC | $38.48 | $12.57 | 206.25% | 34.67x | 34.19x | 5.65x | 2.28x | 1.99x | $155.34M | 5.08% | $1.34B | 16.90 | $2.84B | 24.73 | ||
| MDXG | MIMEDX GROUP INC | $3.56 | $1.59 | 123.87% | 16.95x | -49.86x | 1.36x | 2.18x | 2.63x | $69.36M | 13.12% | $242.94M | 1.64 | $388.07M | 7.12 | ||
| PLX | PROTALIX BIOTHERAPEUTICS INC | $1.98 | $1.77 | 11.65% | 10.42x | 9.12x | 2.07x | 2.37x | 0.90x | $13.00M | 8.23% | $67.23M | 0.84 | $126.30M | 5.66 | ||
| INCY | INCYTE CORP | $95.31 | $67.36 | 41.50% | 13.07x | 12.10x | 3.54x | 3.39x | 1.15x | $1.45B | 7.64% | $5.62B | 28.21 | $15.61B | 8.34 | ||
| SRPT | SAREPTA THERAPEUTICS INC | $17.55 | $4.69 | 274.60% | 29.25x | 5.03x | 0.84x | 1.23x | 4.10x | $109.24M | 5.93% | $1.51B | 14.34 | $2.43B | 29.31 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.